The proposed ANN and Random Forest models highlighted the role of soluble TIM-1 and Gal-9 in predicting mortality among COVID-19 patients, effect that was diminished when anti-interleukin therapy was added into these models. This evidence concerns the gene LGALS9 and COVID-19.